EUVIMEDEUVIMED entdecken
Crossref

Association of carnitine levels with muscle status, fatigue, and mortality in hemodialysis patients

Sovia Salamah, Adrian Post iD, Firas F Alkaff iD, M Rebecca Heiner-Fokkema, Fabian A Vogelpohl, Antonio W Gomes Neto, Karin J R Ipema, Caecilia S E Doorenbos, Eva Corpeleijn, Stephan J L Bakker, Casper F M Franssen

Journal of Nephrology · 20.08.2026 · 39 (4) · 777-784

DOI: 10.1093/joneph/aajaf068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nephrology, online erschienen am 08.06.2026. Verfasst von Sovia Salamah und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Carnitine, Renal Dialysis, Muscle, Skeletal, Fatigue. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Carnitine deficiency is prevalent among hemodialysis patients and may contribute to poor outcomes. In this study, we investigated the relationship of plasma carnitine and carnitine excretion with muscle status, fatigue, and mortality.

Methods

Plasma concentrations of free carnitine and acylcarnitines (AC) were measured using tandem mass spectrometry, and total carnitine concentration and acylcarnitine/free carnitine ratio were calculated. Daily carnitine excretion was estimated from complete collections of intradialytic dialysate and interdialytic urine. Muscle status was assessed by skeletal muscle index and muscle strength. Skeletal muscle index represents muscle mass and was derived from combined dialysate and urinary creatinine excretion; muscle strength was measured using handgrip strength. Fatigue was assessed through a questionnaire.

Results

In 59 hemodialysis patients (mean age 65 years, 37% female, median dialysis vintage 15 months), pre-dialysis plasma free carnitine was 20 [16–26] μmol/L, acylcarnitine was 13 [10–15] μmol/L, acylcarnitine/free carnitine ratio 0.6 [0.5–0.7], and daily carnitine excretion was 237 [192–276] μmol/24 h. In linear regression analyses, plasma total carnitine and free carnitine concentrations and daily carnitine excretion were associated with muscle status. Acylcarnitine/free carnitine ratio was associated with fatigue. During a median follow-up of 22 months, 27% of patients died. Higher daily carnitine excretion was independently associated with a lower risk of mortality.

Conclusion

In hemodialysis patients, better muscle status was associated with higher plasma carnitine and daily carnitine excretion, while fatigue was associated with higher acylcarnitine/free carnitine ratio. Higher daily carnitine excretion was independently associated with lower mortality. Daily carnitine excretion represents a novel biomarker for assessing carnitine adequacy in this population and warrants further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarnitineRenal DialysisMuscle, SkeletalFatigueMuscle StrengthHyperammonemiaHumansFemaleAgedMaleMiddle AgedHand StrengthBiomarkersRisk FactorsTime FactorsMuscular DiseasesCardiomyopathies

Stichwörter der Autor:innen

carnitinehemodialysismortalitymuscle strength

Substanzen

CarnitineacylcarnitineBiomarkers

Autor:innen und Institutionen

  • Division of Nephrology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Division of Pharmacology and Therapy, Department of Anatomy, Histology, and Pharmacology, Faculty of Medicine Universitas Airlangga, Surabaya, Indonesia.
  • Division of Laboratory of Metabolic Diseases, Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Department of Dietetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

ORCID-Profile: Adrian Post, Firas F Alkaff

Zitieren

APA

Salamah, S., Post, A., Alkaff, F. F., Heiner-Fokkema, M. R., Vogelpohl, F. A., Gomes Neto, A. W., Ipema, K. J. R., Doorenbos, C. S. E., Corpeleijn, E., Bakker, S. J. L., & Franssen, C. F. M. (2026). Association of carnitine levels with muscle status, fatigue, and mortality in hemodialysis patients. Journal of Nephrology, 39(4), 777-784. https://doi.org/10.1093/joneph/aajaf068

Vancouver

Salamah S, Post A, Alkaff FF, Heiner-Fokkema MR, Vogelpohl FA, Gomes Neto AW, et al. Association of carnitine levels with muscle status, fatigue, and mortality in hemodialysis patients. Journal of Nephrology. 2026;39(4):777-784. doi:10.1093/joneph/aajaf068

BibTeX
@article{Salamah2026,
  author = {Salamah, Sovia and Post, Adrian and Alkaff, Firas F and Heiner-Fokkema, M Rebecca and Vogelpohl, Fabian A and Gomes Neto, Antonio W and Ipema, Karin J R and Doorenbos, Caecilia S E and Corpeleijn, Eva and Bakker, Stephan J L and Franssen, Casper F M},
  title = {Association of carnitine levels with muscle status, fatigue, and mortality in hemodialysis patients},
  journal = {Journal of Nephrology},
  year = {2026},
  volume = {39},
  number = {4},
  pages = {777--784},
  doi = {10.1093/joneph/aajaf068}
}
Kostenlos starten →